1.19 (-%)
As of Dec 04, 2024
Source:
Alzamend Neuro, Inc is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease, bipolar disorder, major depressive disorder and post-traumatic stress disorder.
Country | United States |
Headquarters | atlanta, georgia |
Phone Number | (844) 722-6333 |
Industry | manufacturing |
CEO | Stephan Jackman |
Website | www.alzamend.com |